Ensysce Biosciences

Yahoo Finance • 11 hours ago

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26%... Full story

Yahoo Finance • 2 months ago

Update: Wall Street Set to Open Lower Friday as Investors Analyze Higher Than Expected Producer Prices; Oil Prices Surge

(Updates to add ticker symbols in the symbol box.) US stocks look set to open lower in Friday's PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium new... Full story

Yahoo Finance • 5 months ago

Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)

New York, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The resear... Full story

Yahoo Finance • 2 years ago

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.59%

Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Oil&Gas, Industrials and Basic Materials sectors led shares higher while losses in the Technology, Telecoms and Consumer Services sectors led shares lower.... Full story

Yahoo Finance • 2 years ago

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%

Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Financials, Technology and Telecoms sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average rose 0.02% to hit a new all time hig... Full story

Yahoo Finance • 3 years ago

Diamond Equity Research Initiates Coverage on Ensysce Biosciences, Inc. (NASDAQ: ENSC)

NEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Ensysce Biosciences, Inc. (NASDAQ: ENSC). The in-depth 21... Full story